| Literature DB >> 27344488 |
Ye Ding1, Chunyong Ding1, Na Ye1, Zhiqing Liu1, Eric A Wold1, Haiying Chen1, Christopher Wild1, Qiang Shen2, Jia Zhou3.
Abstract
Natural products have historically been, and continue to be, an invaluable source for the discovery of various therapeutic agents. Oridonin, a natural diterpenoid widely applied in traditional Chinese medicines, exhibits a broad range of biological effects including anticancer and anti-inflammatory activities. To further improve its potency, aqueous solubility and bioavailability, the oridonin template serves as an exciting platform for drug discovery to yield better candidates with unique targets and enhanced drug properties. A number of oridonin derivatives (e.g. HAO472) have been designed and synthesized, and have contributed to substantial progress in the identification of new agents and relevant molecular mechanistic studies toward the treatment of human cancers and other diseases. This review summarizes the recent advances in medicinal chemistry on the explorations of novel oridonin analogues as potential anticancer therapeutics, and provides a detailed discussion of future directions for the development and progression of this class of molecules into the clinic.Entities:
Keywords: Anticancer agents; Chemical biology; Diterpenoids; Drug discovery; Natural product; Oridonin
Mesh:
Substances:
Year: 2016 PMID: 27344488 PMCID: PMC5003635 DOI: 10.1016/j.ejmech.2016.06.015
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514